Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics

Biochimie

Volumn 83, Issue 7, 2001, Pages 575-581

  Vosseller, K ^a   Wells, L ^a   Hart, G W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

O GlcNAc; Post translational modification; Proteomics; Signal transduction

Indexed keywords

CARBOHYDRATE DERIVATIVE; CYTOPLASM PROTEIN; ENZYME; NUCLEAR PROTEIN; OXYGEN LINKED BETA N ACETYLGLUCOSAMINASE; OXYGEN LINKED BETA N ACETYLGLUCOSAMINE; OXYGEN LINKED BETA N ACETYLGLUCOSAMINE TRANSFERASE; PHOSPHATE; PHOSPHOTRANSFERASE; PROTEOME; SERINE DERIVATIVE; THREONINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACETYLATION; ALZHEIMER DISEASE; BINDING COMPETITION; BINDING SITE; CARBOHYDRATE SYNTHESIS; CELL LEVEL; CELL TYPE; CELLULAR DISTRIBUTION; CLONE; COMPARATIVE STUDY; CYTOSKELETON; DIABETES MELLITUS; DISEASE ACTIVITY; ENZYME MECHANISM; ENZYME REGULATION; GENE SEQUENCE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034851055     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(01)01295-0     Document Type: Review

References (47)

1. Initial sequencing and analysis of the human genome
2. The sequence of the human genome
3. Structure of the adenovirus 2 early mRNAs
4. Correlation between protein and mRNA abundance in yeast
5. Post-translational modification of proteins
6. Posttranslational covalent modification of proteins
7. From proteins to proteomes: Large scale protein identification by two-dimensional electrophoresis and amino acid analysis
8. Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse
9. Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor β receptor
10. The Fas-induced apoptosis analyzed by high-throughput proteome analysis
11. Topography and poypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes
12. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins
13. Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc
14. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate
15. Dynamic glycosylation of nuclear and cytosolic proteins: Cloning and characterization of a unique o-glcnac transferase with multiple tetratricopeptide repeats
16. O-linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats
17. Dynamic O-glycosylation of nuclear and cytoslic proteins: Cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain
18. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins
19. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle
20. Dynamic O-GlcNAcylation of the small heat shock protein aB-crystallin
21. Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18
22. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc
23. O-linked N-acetylglucosamine levels in cerebellar neurons respond reciprocally to perturbations of phosphorylation
24. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas
25. Alternative O-glycosylation O-phosphorylation of the murine estrogen receptor beta
26. Alternative O-glycosylation O-phosphorylation of the murine estrogen receptor beta
27. SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation
28. Characterization of a putative 82 kDa nuclear ligand for the N-acetylglucosamine-binding protein CBP70
29. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions
30. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats
31. Hexosamines and insulin resistance
32. Insulin and glucosamine infusions increase O-linked N-acetylglucosamine in skeletal muscle proteins in vivo
33. Glucose stimulates protein modification by o-linked GlcNAc in pancreatic beta cells: Linkage of o-linked GlcNAc to beta cell death
34. Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells
35. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
36. Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells
37. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny
38. Analysis of receptor signaling pathways by mass spectrometry
39. The dynamic range of protein expression: A challenge or proteomic research
40. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags
41. Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry
42. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine
43. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine
44. Detection of O-linked N-acetylglucosamine (O-GlcNAc) on cytoplasmic and nuclear proteins
45. Specific isolation of O-linked N-acetylglucosamine glycopeptides from complex mixtures
46. Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry
47. Simultaneous detection and identification of O-GlcNAc-modified glycoproteins using liquid chromatography-tandem mass spectrometry